رجوع
65
81
51
87
44
نطاق اليوم
KWD 40.99
KWD 42.08
نطاق 52 أسبوعًا
KWD 35.93
KWD 83.52
حجم التداول
125
متوسط 50 يوم / 200 يوم
KWD 58.21
/
KWD 65.85
الإغلاق السابق
KWD 40.99
Quick Summary
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (631 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 0.5 | 0.3 |
| P/B | 0.2 | 3.0 |
| ROE % | 55.0 | 3.7 |
| Net Margin % | 70.1 | 3.8 |
| Rev Growth 5Y % | 136.8 | 10.0 |
| D/E | 0.0 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
-KWD 11.86
-KWD 16.82 – -KWD 5.79
|
4.08B | 1 |
| FY2029 |
-KWD 31.55
-KWD 44.76 – -KWD 15.41
|
2.48B | 1 |
| FY2028 |
-KWD 40.34
-KWD 57.22 – -KWD 19.70
|
1.26B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-19 | -KWD 8.00 | -KWD 0.81 | +89.9% |
| 2025-11-13 | -KWD 1.11 | -KWD 0.90 | +18.9% |
| 2025-08-14 | KWD 17.22 | KWD 16.06 | -6.7% |
| 2025-05-08 | -KWD 0.77 | -KWD 0.67 | +13.0% |
| 2025-02-20 | -KWD 0.74 | -KWD 0.59 | +20.8% |
| 2024-11-07 | -KWD 0.62 | -KWD 0.56 | +9.7% |
| 2024-08-15 | -KWD 0.61 | -KWD 0.67 | -9.8% |
| 2024-05-16 | -KWD 0.60 | -KWD 0.54 | +9.4% |
Dividend History
Yield
0.00%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
النقاط الرئيسية
Revenue grew 136.77% annually over 5 years — strong growth
ROE of 55.01% indicates high profitability
Net margin of 70.05% shows strong profitability
Debt/Equity of 0.03 — conservative balance sheet
Generating 6.48B in free cash flow
P/E of 0.45 — trading at a low valuation
النمو
Revenue Growth (5Y)
136.77%
Revenue (1Y)14565.56%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
55.01%
ROIC35.04%
Net Margin70.05%
Op. Margin77.66%
الأمان
Debt / Equity
0.03
Current Ratio23.57
Interest Coverage189.81
التقييم
P/E Ratio
0.45
Forward P/EN/A
P/B Ratio0.20
EV/EBITDA-0.17
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 14565.56% | Revenue Growth (3Y) | 417.89% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 136.77% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 9.19B | Net Income (TTM) | 6.44B |
| ROE | 55.01% | ROA | 39.21% |
| Gross Margin | 99.69% | Operating Margin | 77.66% |
| Net Margin | 70.05% | Free Cash Flow (TTM) | 6.48B |
| ROIC | 35.04% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.03 | Current Ratio | 23.57 |
| Interest Coverage | 189.81 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 0.45 | Forward P/E | N/A |
| P/B Ratio | 0.20 | P/S Ratio | 0.31 |
| PEG Ratio | -0.01 | Forward PEG | N/A |
| EV/EBITDA | -0.17 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 224.03% | ||
| Market Cap | 2.89B | Enterprise Value | -1.19B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 9.19B | 62.69M | 342.79M | 103.99M | 292.57M |
| Net Income | 6.44B | -1.08B | -703.74M | -965.61M | -1.02B |
| EPS (Diluted) | 90.04 | -16.24 | -12.44 | -20.90 | -23.75 |
| Gross Profit | 9.17B | 54.82M | 323.61M | 73.28M | 173.75M |
| Operating Income | 7.14B | -1.27B | -572.24M | -816.60M | -1.05B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 16.42B | 9.51B | 1.98B | 1.54B | 2.07B |
| Total Liabilities | 1.63B | 888.86M | 387.15M | 723.90M | 1.14B |
| Shareholders' Equity | 14.80B | 8.62B | 1.59B | 815.91M | 927.80M |
| Total Debt | 484.88M | 391.76M | 119.23M | 443.47M | 787.43M |
| Cash & Equivalents | 4.57B | 480.30M | 449.31M | 1.07B | 1.13B |
| Current Assets | 15.63B | 8.53B | 1.78B | 1.32B | 1.72B |
| Current Liabilities | 663.46M | 403.47M | 284.58M | 195.49M | 334.32M |
درجات الاستراتيجيات
This stock passed the criteria for 5 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#153 of 1052
Custom
Capital Light Compounder
#5 of 219
#283 of 825
#20 of 618
#42 of 203
النشاط الأخير
خرج
Contrarian Investing (David Dreman)
Mar 26, 2026
خرج
Defensive Investing (Benjamin Graham)
Mar 26, 2026
دخل
Cash Flow Compounder
Mar 24, 2026
دخل
Deep Value Investing (Seth Klarman)
Mar 24, 2026
دخل
Capital Light Compounder
Mar 24, 2026
دخل
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
دخل
Contrarian Investing (David Dreman)
Mar 24, 2026
دخل
Defensive Investing (Benjamin Graham)
Mar 24, 2026
دخل
Value Investing (Warren Buffett)
Mar 24, 2026